Skip to main content

Table 2 Genotype and allele distributions in the control subjects and patients with CAD in the Han population

From: The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

 

Total

Men

Women

Variants

CAD n (%)

Control n (%)

P Value

CAD n (%)

Control n (%)

P Value

CAD n (%)

Control n (%)

P Value

rs4886605(SNP1)

         

Genotyping

         

CC

79(20.3%)

96(23.4%)

 

58(19.7%)

51(22.8%)

 

21(22.1%)

45(24.1%)

 

CT

190(48.8%)

200(48.7%)

 

146(49.7%)

119(53.1%)

 

44(46.3%)

81(43.3%)

 

TT

120(30.8%)

115(28.0%)

0.494

90(30.6%)

54(24.1%)

0.248

30(31.6%)

61(32.6%)

0.881

Dominant model

         

CC

79(20.3%)

96(23.4%)

 

58(19.7%)

51(22.8%)

 

21(22.1%)

45(24.1%)

 

TT + CT

310(79.7%)

315(76.6%)

0.297

236(80.3%)

173(77.2%)

0.4

74(77.9%)

142(75.9%)

0.713

Recessive model

         

TT

120(30.8%)

115(28.0%)

0.494

90(30.6%)

54(24.1%)

0.248

30(31.6%)

61(32.6%)

 

CC + CT

269(69.2%)

296(72.0%)

0.373

204(69.4%)

170(75.9%)

0.102

65(68.4%)

126(67.4%)

0.86

Additive model

         

CT

190(48.8%)

200(48.7%)

 

146(49.7%)

119(53.1%)

 

44(46.3%)

81(43.3%)

 

CC + TT

199(51.1%)

211(51.3%)

0.959

148(50.3%)

105(46.9%)

0.434

51(53.7%)

106(56.7%)

0.632

Allele

         

C

348(44.7%)

392(47.7%)

 

262(44.6%)

221(49.3%)

 

86(45.3%)

171(45.7%)

 

T

430(55.3%)

430(52.3%)

0.236

326(55.4%)

227(50.7%)

0.127

104(54.7%)

203(54.3%)

0.918

rs12441817(SNP2)

         

Genotyping

         

CC

83(21.3%)

83(20.2%)

 

65(22.1%)

35(15.6%)

 

18(18.9%)

48(25.7%)

 

CT

205(52.7%)

199(48.4%)

 

154(52.4%)

121(54.0%)

 

51(53.7%)

78(41.7%)

 

TT

101(26.0%)

129(31.4%)

0.235

75(25.5%)

68(30.4%)

0.141

26(27.4%)

61(32.6%)

0.153

Dominant model

         

TT

101(26.0%)

129(31.4%)

0.235

75(25.5%)

68(30.4%)

0.141

26(27.4%)

61(32.6%)

 

CC + CT

288(74.0%)

282(68.6%)

0.09

219(74.5%)

156(69.6%)

0.222

69(72.6%)

126(67.4%)

0.367

Recessive model

         

CC

83(21.3%)

83(20.2%)

 

65(22.1%)

35(15.6%)

 

18(18.9%)

48(25.7%)

 

TT + CT

306(78.7%)

328(79.8%)

0.691

229(77.9%)

189(84.4%)

0.064

77(81.1%)

139(74.3%)

0.208

Additive model

         

CT

205(52.7%)

199(48.4%)

 

154(52.4%)

121(54.0%)

 

51(53.7%)

78(41.7%)

 

CC + TT

184(47.3%)

212(51.6%)

0.226

140(47.6%)

103(46.0%)

0.712

44(46.3%)

109(58.3%)

0.056

Allele

         

C

371(47.7%)

365(44.4%)

 

284(48.3%)

191(42.6%)

 

87(45.8%)

174(46.5%)

 

T

407(52.3%)

457(55.6%)

0.188

304(51.7%)

257(57.4%)

0.07

103(54.2%)

200(53.5%)

0.869

rs4646422(SNP3)

         

Genotyping

         

AA

270(69.4%)

286(69.6%)

 

206(70.1%)

152(67.9%)

 

64(67.4%)

134(71.7%)

 

AG

102(26.2%)

115(28.0%)

 

74(25.2%)

67(29.9%)

 

28(29.5%)

48(25.7%)

 

GG

17(4.4%)

10(2.4%)

0.294

14(4.8%)

5(2.2%)

0.187

3(3.2%)

5(2.7%)

0.759

Dominant model

         

AA

270(69.4%)

286(69.6%)

 

206(70.1%)

152(67.9%)

 

64(67.4%)

134(71.7%)

 

GG + AG

119(30.6%)

125(30.4%)

0.957

88(30.0%)

72(32.1%)

0.59

31(32.6%)

53(28.4%)

0.457

Recessive model

         

GG

17(4.4%)

10(2.4%)

0.294

14(4.8%)

5(2.2%)

0.187

3(3.2%)

5(2.7%)

 

AA + AG

372(95.6%)

401(97.6%)

0.129

280(95.2%)

219(97.8%)

0.129

92(96.8%)

182(97.3%)

0.818

Additive model

         

AG

102(26.2%)

115(28.0%)

 

74(25.2%)

67(29.9%)

 

28(29.5%)

48(25.7%)

 

AA + GG

287(73.8%)

296(72.0%)

0.576

220(74.8%)

157(70.1%)

0.23

67(70.5%)

139(74.3%)

0.496

Allele

         

A

642(82.5%)

687(83.6%)

 

486(82.7%)

371(82.8%)

 

156(82.1%)

316(84.5%)

 

G

136(17.5%)

135(16.4%)

0.573

102(17.3%)

77(17.2%)

0.946

34(17.9%)

58(15.5%)

0.468

rs1048943(SNP4)

         

Genotyping

         

CC

20(5.1%)

17(4.1%)

 

15(5.1%)

8(3.6%)

 

5(5.3%)

9(4.8%)

 

CT

152(39.1%)

148(36.0%)

 

115(39.1%)

80(35.7%)

 

37(38.9%)

68(36.4%)

 

TT

217(55.8%)

246(59.9%)

0.47

164(55.8%)

136(60.7%)

0.45

53(55.8%)

110(58.8%)

0.888

Dominant model

         

TT

217(55.8%)

246(59.9%)

 

164(55.8%)

136(60.7%)

 

53(55.8%)

110(58.8%)

 

CC + CT

172(44.2%)

165(40.1%)

0.244

130(44.2%)

88(39.3%)

0.26

42(44.2%)

77(41.2%)

0.626

Recessive model

         

CC

20(5.1%)

17(4.1%)

 

15(5.1%)

8(3.6%)

 

5(5.3%)

9(4.8%)

 

TT + CT

369(94.9%)

394(95.9%)

0.499

279(94.9%)

216(96.4%)

0.402

90(94.7%)

178(95.2%)

0.87

Additive model

         

CT

152(39.1%)

148(36.0%)

 

115(39.1%)

80(35.7%)

 

37(38.9%)

68(36.4%)

 

CC + TT

237(60.9%)

263(64.0%)

0.371

179(60.9%)

144(64.3%)

0.429

58(61.1%)

119(63.6%)

0.671

Allele

         

C

192(24.7%)

182(22.1%)

 

145(24.7%)

96(21.4%)

 

47(24.7%)

86(23.0%)

 

T

586(75.3%)

640(77.9%)

0.231

443(75.3%)

352(78.6%)

0.223

143(75.3%)

288(77.0%)

0.645

  1. CAD, coronary artery disease; SNP, single-nucleotide polymorphism.